Cases & Deals

  • Home
  • Practices
  • Takeda Pharmaceutical undergoes investigation involving alleged misconduct relating to investigator-initiated sponsored study on hypertension medicine

Share

Takeda Pharmaceutical undergoes investigation involving alleged misconduct relating to investigator-initiated sponsored study on hypertension medicine

March 2014

Client(s) Takeda Pharmaceutical Company Limited

Jones Day, as a third-party organization, conducted an investigation for Takeda Pharmaceutical Company Limited in a matter involving alleged misconduct relating to an investigator-initiated sponsored study on its hypertension medicine, known as Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.